ArticleBreast cancer research : BCR2024

Correction: NSABP FB-10: a phase Ib/II trial evaluating ado-trastuzumab emtansine (T-DM1) with neratinib in women with metastatic HER2-positive breast cancer.

Samuel A Jacobs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.